Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of Sublingual vs Oral Aspirin in Healthy Volunteers
NCT04792723Phase 1Unknown
- Sponsor
- Vita Green
- Start
- Mar 2021
- Primary completion
- Jul 2021
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, randomised, open-label trial of aspirin in cardiovascular diseases (CVD) (2 arms), sponsored by Vita Green. Primary endpoint: Plasma-concentration time data of salicylic acid. Status: unknown.
02
Drugs
aspirin
03
Conditions
cardiovascular diseases (CVD)
Beyond the preview
Go deeper on NCT04792723.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04792723.